Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine-Reference-Cited by-同舟云学术

Prognostic analysis according to European LeukemiaNet 2022 risk stratification for elderly patients with acute myeloid leukemia treated with decitabine

Published:2024-03-03 Issue:1 Volume:29 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Kim Mihee¹,Ahn Seo-Yeon¹,Kim TaeHyung²³,Jung Sung-Hoon¹,Song Ga-Young¹,Yang Deok-Hwan¹,Lee Je-Jung¹,Kim Mi Yeon⁴,Park Ju Heon⁴,Shin Myung-Geun⁴,Ahn Jae-Sook¹⁴,Kim Hyeoung-Joon¹⁴,Kim Dennis Dong Hwan⁵

Affiliation:

1. Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Republic of Korea

2. Department of Computer Science, University of Toronto, Toronto, Canada

3. The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada

4. Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Jeollanam-do, Republic of Korea

5. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada

Funder

Ministry of Science, ICT, and Future Planning

National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea

Chonnam National University Hwasun Hospital Institute for Biomedical Science

Korean Government

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2024.2324417

Reference43 articles.

1. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

2. Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older

3. Park E-H Lee H Won Y-J et al. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012. Br. 2015;50(4):204–217.

4. Human acute myeloid leukemia stem cells: evolution of concept;Shin D-Y.;Blood Res,2022

5. Prognostic factors in elderly patients with AML and the implications for treatment;Erba HP.;ASH Education Program Book,2007